Mitochondrial tRNA Mutations Associated With Essential Hypertension: From Molecular Genetics to Function

Area of Science:

• Cardiovascular Disease Research
• Mitochondrial Genetics
• Molecular Biology

Background:

• Essential hypertension (EH) is a prevalent global cardiovascular disease with significant morbidity.
• EH pathogenesis involves genetic and environmental factors, with mitochondrial DNA (mtDNA) genotype playing a role.
• Specific mtDNA mutations in tRNA genes have been associated with maternally inherited hypertension.

Purpose of the Study:

• To review known mutations in mtDNA-encoded tRNA genes.
• To discuss potential mechanisms linking these mutations to hypertension.
• To explore the role of altered tRNA structure and function in EH pathophysiology.

Main Methods:

• Literature review of studies on mtDNA mutations and hypertension.
• Analysis of identified tRNA gene mutations and their functional consequences.
• Discussion of molecular mechanisms, including metabolic disorders and oxidative stress.

Main Results:

• Several specific tRNA mutations (e.g., tRNA^Ile m.4263A>G, tRNA^Met m.4435A>G) are associated with hypertension.
• These mutations can impair tRNA structure, affecting protein synthesis.
• Consequent defects in oxidative phosphorylation, ATP synthesis, and increased reactive oxygen species production are observed.

Conclusions:

• mtDNA mutations in tRNA genes represent a potential genetic factor in essential hypertension.
• Altered mitochondrial function due to these mutations contributes to EH development.
• Further research into these genetic links could offer new insights into hypertension etiology.